MarketPeel
Insider Trading Intelligence
MG

Melanie Gloria

IMVT
CHIEF OPERATING OFFICER · IMMUNOVANT, INC. · CIK 0001973838
FILING MIX · LIFETIME35%/65%
BUYS
6
SELLS
11
TOTAL VALUE
$1.38M
COMPANIES
1
ACTIVE SINCE
Nov 2024
HOLDINGS NOW
227,359
AVG SELL PX
$30.49
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 17 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Melanie Gloria, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+50.00%+2.88%+1.40%+1.48%+0.61%
14d6+50.00%+0.32%+1.28%-0.96%-3.71%
30d6+50.00%+2.56%-1.31%+3.87%+2.25%
60d6+0.00%+11.75%+4.38%+7.37%+6.39%
90d6(1 pending)+0.00%+22.02%+5.17%+11.76%+11.76%
180d6(4 pending)+0.00%+27.07%+13.76%+13.31%+13.31%
1y6(6 pending)
2y6(6 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
IMVT · 227,359 shares · as of Jun 26, 2026
063,486126,972190,458253,94420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2025
2025
2025
2025
2026
2026
FLOW · 6 buys / 11 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
14,748$38.18$563.1K227,359Jun 26, 2026Jun 26, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
2,966$38.95$115.5K224,393Jun 26, 2026Jun 26, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
249$30.41$7.6K244,973May 20, 2026May 22, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
1,698$32.95$55.9K242,107May 20, 2026May 22, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
1,168$32.15$37.6K243,805May 20, 2026May 22, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
8,722$24.83$216.6K245,222Apr 8, 2026Apr 10, 2026View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
121,063121,063Apr 7, 2026Apr 9, 2026View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
83,671253,944Apr 7, 2026Apr 9, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
859$28.16$24.2K171,215Feb 25, 2026Feb 27, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
942$28.90$27.2K170,273Feb 25, 2026Feb 27, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
1,437$26.98$38.8K172,074Feb 25, 2026Feb 27, 2026View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
2,375$23.97$56.9K173,511Nov 20, 2025Nov 21, 2025View →
IMVT
IMMUNOVANT, INC.
SALE
Chief Operating Officer
10,251$23.54$241.3K175,886Nov 20, 2025Nov 21, 2025View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
76,181186,137Apr 1, 2025Apr 3, 2025View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
107,297107,297Apr 1, 2025Apr 3, 2025View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
109,956109,956Nov 18, 2024Nov 20, 2024View →
IMVT
IMMUNOVANT, INC.
PURCHASEGRANT
Stock grant
137,446137,446Nov 18, 2024Nov 20, 2024View →
Other insiders · IMVT
Loading peer insiders…
About this filer
CIK 0001973838
ROLE
Chief Operating Officer
PRIMARY
IMVT
COMPANIES
1
ACTIVE SINCE
Nov 2024
MARKETPEEL · /INSIDER/0001973838DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback